# Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation

> **NCT00677963** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 18 (estimated)

## Conditions studied

- Carotid Artery Stenosis
- Atherosclerosis

## Interventions

- **DRUG:** sulphur hexafluoride, gadopentate dimeglumine

## Key facts

- **NCT ID:** NCT00677963
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2011-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677963, "Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00677963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*